Abbvie Inc
NYSE: ABBV
$180.00
+$1.61 (+0.9%)
Closing Price on December 24, 2024
ABBV Articles
Monday's top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under Armour and Wynn Resorts.
Published:
Last Updated:
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
Published:
These five high-conviction medical technology health care ideas from Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well during the fourth...
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service and WPX Energy.
Published:
These five Dividend Aristocrats have sizable upside to the Wall Street targets and pay at least 4%. In a market that is very long in the tooth, they make sense now.
Published:
A hot equity market from some popular stocks has overshadowed the steady payouts from many, less spectacular, but reliable companies. Here are eight overlooked stocks.
Published:
These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of safety. They have come way in from their 52-week...
Published:
Monday's top analyst upgrades and downgrades included AbbVie, DuPont, Etsy, Expedia, Exxon Mobile, Kansas City Southern, Merck, Microsoft, Pinterest, Qualcomm, Visa and Yum! Brands.
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Ambarella, Apple, DocuSign, Home Depot, Lowe's, Micron Technology, Nike, PG&E, ViacomCBS, YETI and Yext.
Published:
Alpine Immune Sciences shares doubled on Thursday after the company announced a license agreement with AbbVie for its ALPN-101.
Published:
Some mergers can add a nice shot in the arm for an acquirer. After years of being focused on Humira, AbbVie has now completed its acquisition of Allergan.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, ANGI Homeservices, CBOE, Darden Restaurants, Hess, Lululemon Athletica, MongoDB, PayPal, Shopify, Slack and Zynga.
Published:
Wednesday's top analyst upgrades and downgrades included AbbVie, American Electric Power, Anheuser-Busch InBev, Arconic, Baidu, Best Buy, Co-Diagnostics, Cree, Exelon, Home Depot, NRG Energy,...
Published:
Monday's top analyst upgrades and downgrades included AbbVie, Best Buy, Conagra Brands, Dick's Sporting Goods, General Motors, Hilton Worldwide, NetApp, Nvidia, Redfin, TJX Companies, Vale and Yelp.
Published: